Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective

Henningfield JE, Ashworth J, Heal DJ, Smith SL.

J Psychopharmacol. 2023 Jan 1:2698811221140004.

View publication